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INTRODUCTION 
C l i n i c a l o b s e r v a t i o n s have s u g g e s t e d an a s s o c i a t i o n 
between i o d i n e i n t a k e and t h e o c c u r a n c e of autoimmune t h y r o i -
d i t i s i n man ( 1 , 2 ) , w h i l e i n a r e a s w i t h endemic g o i t e r p r e v a -
l e n c e due to i o d i n e d e f i c i e n c y a l o w e r i n c i d e n t of 
Hashimoto's t h y r o d i t i s was found ( 3 ) « O t h e r s , however, have 
c o n t e s t e d t h e s e c l a i m s ( 4 > 5 ) « E x p e r i m e n t a l l y , t h i s a s s o c i a -
t i o n has been d e m o n s t r a t e d w i t h g e n e t i c a l l y s u s c e p t i b l e 
c h i c k e n ( 6 ) , r a t s ( 7 ) and dogs ( 8 ) on a h i g h i o d i z e d d i e t . I n 
t h e p r e s e n t s t u d y , we were i n t e r e s t e d i n t h e e f f e c t i o d i n e 
would have on t h e f u n c t i o n a l immune r e s p o n s e of human T-
l y m p h o c y t e s i n c o - c u l t u r e s w i t h a u t o l o g o u s t h y r o i d e p i t h i l i a l 
c e l l s ( T E C s ) . C l a s s i c a l l y , o n l y immunocompetent c e l l s , namely 
macrophages a r e a b l e t o p r e s e n t a n t i g e n t o g e t h e r w i t h t h e 
i m m u n r e g u l a t o r y c l a s s - I I s u r f a c e ant i g e n ( 9 ) • T h e s e c l a s s - I I 
a n t i g e n s ( i n man HLA-D l o c i i ) can a l s o be found i n v i v o ( 1 0 ) 
and induced by v a r i o u s a g e n t s i n v i t r o ( l l ) on T F C s . With t h i s 
background our i n v i t r o model s y s t e m was d e s i g n e d to i ) modu-
l a t e HLA-D e x p r e s s i o n on TECs and i i ) to i n v e s t i g a t e , i f a 
p o t e n t i a l i o d i d e i n d u c e d a u t o a n t i g e n on TECs would be p r e s e n -
t e d t h r o u g h HLA-D to a u t o l o g o u s T - l ymphocytes and t h u s i n i -
t i a t e a p r o l i f e r a t i v e c e l l u l a r immunresponse. I n o r d e r t o 
modulate t h e h y p o t h e t i c a l i o d i n e i n d u c e d a u t o a n t i g e n t h e 
i n f l u e n c e of Methimazole (MMI) and P e r c h l o r a t e (PC) on t h e 
c o - c u l t u r e s y s t e m was t o be s t u d i e d . MMI has been s u s p e c t e d 
t o a c t immune s u p p r e s s i v e l y d u r i n g s u p p r e s s i o n t h e r a p y of 
G r a v e s ' d i s e a s e (GD) i n v i v o and on a n t i b o d y s y n t h e s i s i n 
v i t r o ( 1 2 ) . I n t e r e s t i n g l y , when MMI t h e r a p y i n GD h y p e r t h y r o i -
d i sm was compared t o PC t r e a t m e n t , which c l e a r l y i s no immuno 
s u p p r e s s i v e a g e n t , both drugs had t h e same e f f e c t on t h e 
p r o d u c t i o n of t h y r o i d s t i m u l a t i n g a n t i b o d i e s (TSab) ( 1 3 ) « 
METHODS 
S u b j e c t s 
T h y r o i d t i s s u e was o b t a i n e d from p a t i e n t s w i t h GD or non 
t o x i c g o i t e r (NTG). GD p a t i e n t s w i t h t h e e x c e p t i o n of two 
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where i n cpm = cpm (TEC + L y ) - cpm (TEC) - cpm ( L y ) 
I n d i r e c t i m m u n o f l o r e s c e n c e ( I F ) ( 1 1 ) . 
TEC were p l a t e d and c u l t u r e d on 8 chamber g l a s s s l i d e s 
( 2 0 x 1 0 ^ ) c e l l s (chamber) i n t h e a p p r o p r i a t e medium w i t h or 
w i t h o u t i n d u c i n g a g e n t s . A f t e r 4 days TECs were washed and 
i n c u b a t e d w i t h s p e c i f i c m onoclonal a n t i b o d i e s f o r HLA-D or M-
a n t i g e n . Double s t a i n e d s l i d e s were d e v e l o p e d w i t h a mouse 
IgG or a human IgG c o u p l e d t o F I T C or TRITC , r e s p e c t i v e l y . 
MATERIALS 
C o l l a g e n a s e ( D i s p a s e I I ) was from B o e h r i n g e r , Mannheim, 
FRG. F e t a l c a l f serum ( F C S ) , I s c o ve ( T ) medium and a l l c e l l 
c u l t u r e a d d i t i v e s were from Biochrom, West B e r l i n . Mono-
c l o n a l s , T ü - 2 2 / 3 5 / 3 9 and i n t e r l e u k i n 2 were from 
B i o t e s t , D r e i e i c h , F R G . F I T C and TRITC c o n j u g a t e d s e c o n d a n t i -
b o d i e s were from DAKOPATT, Hamburg, FRG. I n t e r f e r o n ^ , M e t h i -
mazole and a l l hormone a d d i t i v e s were from Sigma Chemie, 
Munich, FRG. Sodium i o d i d e and P o t a s s i u m P e r c h l o r a t e were 
from E. Merck, Darmstadt, FRG. T h y r o t r o p i n ( T h y r e o s t i m u l i n ) 
was from Organon, Munich, FRG. M i c r o L a b s l i d e s ( M i l e s ) P h y t o -
h e m a g g l u t i n i n and sheep e r y t h r o c y t e s were from Flow, Mecken-
heim, FRG. A C e l l h a r v e s t e r , M u l t i w a s h 2 0 0 0 , D y n a t e c h , Denken-
d o r f , FRG and a F l o u r e s c e n c e - P h o t o m i c r o s c o p e , BH -2 from 
OLympus Europe, Hamburg, FRG were u s e d . 
RESULTS 
We d e m o n s t r a t e s i m u l t a n e o u s e x p r e s s i o n of HLA-D and M-
a n t i g e n , when TECs a r e p r e i n c u b a t e d w i t h bTSH i n 5H ( s e r u m 
f r e e ) medium. I n c o n t r a s t , no M-antigen i s r e - e x p r e s s e d i n 
TECs a f t e r i n c u b a t i o n w i t h PHA or I F N # ( T a b l e 1 . ) . The HLA-D 
T a b l e 1 . I n v i t r o E x p r e s s i o n 1 of HLA-D Polymorph i s m and 
Mi c r o s o m a l A n t i g e n i n P r e i n c u b a t e d TEC C u l t u r e s . 
DR DP/DR M 
PHA + + + + + 0 0 
+ NaI + + + 0 0 
TSH + + + 0 + + + 
+ NaI + + 0 + + 
I FN ft* + + + + + + + + 0 
+ NaI + + + + + 0 
Nal U ) 2 0 0 0 
MM I ( + ) 0 0 0 
PC 0 0 0 0 
Medium ( + ) ( + ) 0 ( + ) 
^ - a s s e s s e d by I F 2 - i n some GD-TECs s p o n t a n e o u s l y 
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c a s e s were i o d i n e l o a d e d f o r 10 days b e f o r e s u r g e r y . They 
a l s o had TSab and 6 / 7 had m i c r o s o m a l (M) a n t i b o d i e s . P a t i e n t s 
w i t h NTG were a l l v o i d of t h y r o i d a n t i b o d i e s . 
T h y r o i d e p i t h e l i a l c e l l s 
T h y r o i d t i s s u e was minced, washed and d i g e s t e d e n z y m a t i -
c a l l y w i t h 4 mg/ml c o l l a g e n a s e two t i m e s f o r 90 m i n u t e s a t 37 
C. C e l l s t h e n were washed, s e p a r a t e d from d e b r i s and e r y t h r o -
c y t e s by d e n s i t y c e n t r i g f u g a t i o n , washed a g a i n and p l a t e d i n 
I s c o v e medium c o n t a i n i n g i n s u l i n , h y d r o c o r t i s o n e , s o m a s t a t i n , 
human t r a n s f e r r i n and g l y - h i s - l i s t r i p e p t i d e i n 0,5% f e t a l 
c a l f serum ( F C S ) (5-hormone,(5H) medium). 
C e l l C u l t u r e s 
TECs were a l l o w e d t o adhere o v e r n i g h t i n 250 ml / 9 6 w e l l 
f l a t bottom M i c r o t i t e r p l a t e s ( 2 0 x l 0 3 c e l l s / w e l l ) . A f t e r 
washing w i t h medium, TECs were i n c u b a t e d f o r 4 - 5 days w i t h 
I n t e r f e r o n * ( I F N % ) 10 U/ml, P h y t o h e m a g g l u t i n i n (PHA) 0 . 5 
ug/ml, b o v i n e t h y r o t r o p i n (bTSH) 1-100 mU/ml t o g e t h e r w i t h or 
w i t h o u t sodium i o d i d e ( N a l ) , 0 . 1 mM, MMI, 1 -100 uM and PC , 
1-100 uM. 
On day 5 a f t e r s t a r t i n g TEC c u l t u r e s p e r i p h e r a l b l o o d was 
drawn from t h e donor of t h e t h y r o i d t i s s u e . Lymphocytes were 
p r e p a r e d by d e n s i t y c e n t r i f u g a t i o n and T - c e l l s were s e p a r a t e d 
by r o s e t t i n g w i t h sheep r e d blood c e l l s ( S R B C ) . 
When i n t r a - t h y r o i d a l l ymphocytes were p r e p a r e d , t h e 
i n i t i a l TEC s u s p e n s i o n a f t e r c o l l a g e n a s e d i g e s t i o n was d i -
v i d e d up. One p a r t was used f o r e s t a b l i s h i n g TEC c u l t u r e s , 
w h i l e t h e o t h e r p a r t was a l l o w e d t o adhere o v e r n i g h t , o n l y 
t h a t t h e r e a f t e r t h e non-adherend c e l l s were p u r i f i e d by 
d e n s i t y c e n t r i f u g a t i o n . A l l c e l l s b a nding w i t h lymphocytes 
were washed, f r o z e n and s t o r e d i n l i q u i d n i t r o g e n u n t i l use 
on t h e f i f t h day of a u t o l o g o u s TEC c u l t u r e s . The y i e l d of 
i n t r a t h y r o i d a l T - l y m p h o c y t e s was v e r y v a r i a b l e . Depending on 
t h e s o u r c e o f t h e t h y r o i d t i s s u e 1-30 m i l l i o n T-lymphocytes 
c o u l d be o b t a i n e d . 
C o - c u l t u r e s 
A f t e r t h e p r e i n c u b a t i o n p e r i o d f o r TECs 2 - 4 x 1 0 ^ T-lym-
p h o c y t e s were added t o each M i c r o t i t e r w e l l ( 1 - 2 xlO c e l l s 
/ml) u s i n g I s c o v e medium-T supplemented w i t h 15% i n t e r l e u k i n 
2 ( I L 2 ) . C o - c u l t u r e s were i n c u b a t e d f o r a n o t h e r 6 d a y s , 
w h e r e a f t e r t h e 24 hour t r i t i a t e d t h y m i d i n ( 3HTdR) uptake was 
measured. 
3HTdR u p t a k e 
To e a c h M i c r o t i t e r w e l l 0 . 5 M C i / 5 0 u l 3HTdR ( 2 Ci/mmol) 
were added. A f t e r 24 h o u r s t h e non a t t a c h e d c e l l s i n c o -
c u l t u r e s were r e s u s p e n d e d , h a r v e s t e d w i t h a c e l l - h a r v e s t e r on 
t o c e l l u l o s e a c e t a t e f i l t e r , p r e c i p i t a t e d w i t h 10% t r i - c h l o r -
a c e t i c a c i d ( T C E ) and washed w i t h 96% c o l d e t h a n o l . F i l t e r s 
were d r i e d , punched out and d i s o l v e d i n s c i n t i l l a t i o n 
c o c k t a i l . Samples were s e t up i n q u a d r u p l i c a t e s and s t i m u l a -
t i o n i n d i c e s were c a l c u l a t e d a s : 
cpm ( + I L 2 ) / cpm (- I L 2 ) = S I + SD 
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T a b l e 2 . HLA-D E x p r e s s i o n and Aut o l o g o u s T-Lymphocyte 
Response i n C o - C u l t u r e s w i t h T E C s . 
HLA-D S I + SD 
PHA 8c + + + 1 .5 ±o, .4 + NaI + + 5. .6 ± 1 . . 1 + " +MMI + l , . 1 + 0. .6 
+ 11 + PC + 0 , .9 ± 0 . .6 
IFN * + + + 1, .6 ± 0 . . 2 
+ Nal + + 5-. 1 ± 0 . .6 + "+MMI + + 1 , ,8 + 0 . .5 
+ "+PC + 1 . • 5 ±0 . .6 
TSH + + 1 . .2 + 0 . .7 + NaI + 4« . 1 ±0 . ,8 
+ "+MMI + 0 . .9 ± 0 . -4 + "+PC + 1 . ,0 ± 0 . .3 
Medium - 1 . ,8 + 0 . -5 
& - I F * P < 0 . 0 5 •** p < 0 . 0 1 
i n d u c i n g a g e n t s a l s o d i f f e r , when HLA-D polymorphism was 
a s s e s s e d . W h i l e IFM s t r o n g l y i n d u c e s HLA-DQ, PHA and TSH 
i n c u b a t e d T E C s d i s p l a y o n l y DR/DP and no -DQ ( T a b l e 1 ) . 
Although Nal i s r e d u c i n g f l o u r e s c e n c e s t a i n on i n d u c e d T E C s , 
t h e r e i s no s u p p r e s s i n g of HLA-D o b s e r v e d . The same a p p l i e s 
f o r MMI and PC a t c o n c e n t r a t i o n l o w e r t h a n 0 . 1 mM i n c u l -
t u r e s . I n some TECs from G D - p a t i e n t s a s p o n t a n e o u s HLA-D 
e x p r e s s i o n o c c u r s , which d i s a p p e a r s a f t e r 3 days i n c u l t u r e . 
As shown i n T a b l e 2 . o n l y t h o s e c o - c u l t u r e s , w h e r e HLA-D 
was i n d u c e d t o g e t h e r w i t h Nal i n c u b a t i o n , a u t o l o g o u s T-
lymphocytes responded w i t h a s i g n i f i c a n t l y i n c r e a s e d p r o l i f e -
r a t i o n . T h i s a u t o l o g o u s MLR l i k e r c a c t i o n was a b o l i s h e d by 
s i m u l t a n e o u s i n c u b a t i o n w i t h MMI or PC. Both a g e n t s , however, 
d i d not s u p p r e s s HLA-D e x p r e s s i o n under t h e same p r e i n c u b a -
t i o n c o n d i t i o n s . 
T a b l e 3« P r o l i f e r a t i v e Response i n C o - C u l t u r e s of TECs w i t h 
A u t o l o g o u s I n t r a - t h y r o i d a l T - lymphocytes from GD-
P a t i e n t s . 
I F N % IFN^+Nal Con A 
P a t i e n t 1 § 1 . 6 + 0 . 4 1.3 ± 0 . 5 5 . 2 + 0 . 4 
P a t i e n t 2 1 . 6 + 0 . 2 1 . 6 + 0 . 5 6 . 9 + 0 . 6 
§-SI + SD 
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When i n t r a - t h y r o i d a l T - l y mphocytes were u s e d under i d e n -
t i c a l c o - c u l t u r e c o n d i t i o n s , no p r o l i f e r a t i v e r e s p o n s e was 
o b s e r v e d on IFNy/Nal p r e i n c u b a t e d TECs ( T a b l e 3 ) , a l t h o u g h 
t h e ConA T-lymphocyte r e s p o n s e was s t i l l i n t a c t and t h e T-
s u p p r e s s o r T - h e l p e r r a t i o were not a l t e r e d ( v i s u a l l y c h e c k e d 
by I F ) . 
There a p p e a r s t o be a d i f f e r e n c e i n T-lymphocyte r e -
s p o n s e s a c c o r d i n g t o i o d i n e a d m i n i s t r a t i o n b e f o r e s u r g e r y . 
C o - c u l t u r e s of G D - p a t i e n t s which have not been l o a d e d w i t h 
i o d i n e t e n d t o have l o w e r S I t h a n t h o s e of p a t i e n t s 
"plummered" f o r 10 days ( T a b l e 4 « ) - When c o - c u l t u r e s were s e t 
up w i t h TECs from p a t i e n t s w i t h NTG on l y 4 / 1 5 T - c e l l r e s p o n -
s e s were o b s e r v e d ( n o t shown). 
T a b l e 4 . The I n f l u e n c e of I o d i n e Load on t h e Autologous T-
Lymphocyte r e s p o n s e i n C o - C u l t u r e s w i t h TECs from 
G D - P a t i e n t s . 
"Plummer" S I + SD 
P a t i e n t 1 no 2 . 8 +0. .7 
P a t i e n t 2 no 3 . i + 0 , .4 
P a t i e n t s , n = 7 y e s 5 . 8 + 0, .6 
i t i t I o d i n e l o a d e d f o r 10 days pre-Op. 
DISCUSSION 
Our i n v i t r o c o - c u l t u r e s y s t e m a p p e a r s t o be a model f o r 
i o d i n e i n d u c e d a u t o i m m u n i t y ( 2 ) . I t i s comparable t o t h e a n i m a l 
models u s i n g obese c h i c k e n ( 6 ) or BB/W r a t s ( 7 ) • L i k e w i s e i n 
t h o s e models t h e a u t o l o g o u s T-lymphocyte r e s p o n s e i n our i n 
v i t r o s y s t e m i s g e n e t i c a l l y s u s z e p t i b i l i t y d e p e n d e n t , s i n c e 
1 0 / 1 0 GD-donors w i t h p r o l i f e r a t i v e r e s p o n s e s a r e c o n t r a s t e d 
by o n l y 4 / 1 5 N T G - p a t i e n t s . Wether t h i s c o u l d r e f l e c t a l t e r n a t l i -
v e l y t h e a c t u a l i o d i n e d e f i c i e n c y i n t h e g o i t r o u s t h y r o i d i s 
not y e t understood.One h i n t i n t h a t d i r e c t i o n c o u l d be t h e 
d i f f e r e n c e i n magnitude of t h e r e s p o n s e i n i o d i n e l o a d e d and 
unloaded G D - p a t i e n t s . 
I n o r d e r t o o b t a i n a T-lymphocyte r e s p o n s e two r e q u i r e -
ments have t o be met: 1.An a u t o a n t i g e n h a s t o be i n d u c e d . I n 
our model t h i s i s a p p a r e n t l y i o d i n e i n d u c e d and 
d e p e n d e n t , s i n c e p r e v e n t i n g t h e i o d i n e uptake w i t h PC 
a b o l i s h e s t h e r e s p o n s e . 2 . The a u t o a n t i g e n has t o be 
p r e s e n t e d t o immunocompetent l y m p h o c y t e s . l t a p p e a r s t h a t t h e 
t h y r o c y t e i s p r e s e n t i n g i t s own a u t o a n t i g e n v i a HLA-D,since 
HLA-D e x p r e s s i o n o f TECs i s a c o n d i t i o n f o r t h e r e s p o n s e . T h i s 
would c o n f i r m f i n d i n g s , w h e r e c l a s s - I I a n t i g e n e x p r e s s i n g 
e p i t h e l i a l c e l l s were a b l e t o p r e s e n t v i r a l p r o t e i n s ( 1 4 ) • M M I 
does not s u p p r e s s c l a s s - I I a n t i g e n , w h i c h r e f l e c t s p r e v i o u s 
f i n d i n g s i n r e c u r r e n t h y p e r t h y r o i d i s m od G D - p a t i e n t s ( 1 5 ) • 
Moreover,the s i m i l a r b e h a v i o u r of MMI and PC i n our s y s t e m 
r e c a l l s f i n d i n g s i n GD t h e r a p y , w h e r e both agent had t h e same 
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e f f e c t on t h y r o i d a n t i b o d y t i t e r s d u r i n g t h e c o u r s e of t h e 
d i s e a s e ( 1 3 ) • 
Our f a i l u r e t o produce a p r o l i f e r a t i v e r e s p o n s e w i t h i n t r a -
t h y r o i d a l T -lymphocytes i s p u z z l i n g and h a r d t o 
i n t e r p r e t . A l t h o u g h t h e Ts/Th r a t i o and t h e m i t o g e n i c T-
lymphocyte r e s p o n s e a r e not a l t e r e d , t h e r e might be a l o s s of 
T - h e l p e r c e l l s d u r i n g t h e p r e p a r a t i o n p r o c e d u r e . 
Ongoing s t u d i e s i n our l a b o r a t o r y aire d e s i g n e d t o d e f i n e 
t h e i o d i n e dependent a u t o a n t i g e n . 
SUMMARY 
TSH,in c o n t r a s t t o PHA and I F N # , i n d u c e s i n serum f r e e 
medium b o t h , c l a s s - I I and m i c r o s o m a l a n t i g e n . T h e c l a s s - I I 
polymorphism d i s p l a y s DR/DP l o c i i r a t h e r t h a n DQ,while IFN 
a l w a y s s t r o n g l y i n d u c e s DQ.Iodine p r o d u c e s a u t o a n t i g e n i n 
TECs which t o g e t h e r w i t h c l a s s - I I e x p r e s s i o n g i v e s r i s e t o an 
a u t o l o g o u s mixed lymphocyte r e a c t i o n - l i k e r e s p o n s e . T h e 
i o d i n e i n d u c e d immune r e s p o n s e i n c o - c u l t u r e s p r e v a i l s i n 
TECs from G D - p a t i e n t s ( 1 0 / 1 0 ) , w h i l e o n l y 4 / 1 5 NTG-TECs gave 
res p o n s e . M e h i m a z o l e as w e l l as P e r c h l o r a t e a b o l i s h t h e r e -
sponse , a l t h o u g h t h e y do not s u p p r e s s t h e c l a s s - I I e x p r e s s i o n 
of T E C S . I o d i n e c o u l d not i n d u c e a p r o l i f e r a t i v e r e s p o n s e w i t h 
i n t r a - t h y r o i d a l lymphocytes .The m i t o g e n i c T - c e l l r e s p o n s e i s 
not a b o l i s h e d . R e s p o n s e s i n i o d i n e l o a d e d p a t i e n t s a r e h i g h e r 
t h a n i n t h e two G D - p a t i e n t s who were not " plummered" b e f o r e 
o p e r a t i o n . 
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